Survey data showed that patients may prefer tubeless over tubed insulin pumps and hybrid closed loop over multiple daily injections.

An automated insulin delivery system received FDA approval for adults with type 2 diabetes on insulin therapy, according to an industry press release. The FDA approved an expanded indication for the ...

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management ...

At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed-loop automated insulin delivery system.

FDA approves 1st automated, tubeless insulin pump for people with Type 1 diabetes The Omnipod 5 will be immediately available for people ages 6 to 70.

Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living with diabetes, now shipping in the United States.

Automated insulin delivery (AID) systems — also known as hybrid closed-loop systems or artificial pancreas systems — combine an insulin pump, a CGM, and an algorithm that automatically adjusts ...